Inovio Pharmaceuticals Inc - Asset Resilience Ratio

Latest as of September 2025: 20.52%

Inovio Pharmaceuticals Inc (INO) has an Asset Resilience Ratio of 20.52% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

$14.24 Million

Cash + Short-term Investments

Total Assets

$69.39 Million

All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2000–2024)

This chart shows how Inovio Pharmaceuticals Inc's Asset Resilience Ratio has changed over time. Check Inovio Pharmaceuticals Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Inovio Pharmaceuticals Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see INO market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$14.24 Million	20.52%
Total Liquid Assets	$14.24 Million	20.52%

Asset Resilience Insights

Good Liquidity Position: Inovio Pharmaceuticals Inc maintains a healthy 20.52% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Inovio Pharmaceuticals Inc Industry Peers by Asset Resilience Ratio

Compare Inovio Pharmaceuticals Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
argenx NV ADR NASDAQ:ARGX	Biotechnology	10.93%
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Asymchem Laboratories Tian Jin Co Ltd SHE:002821	Biotechnology	5.07%
Amicus Therapeutics Inc NASDAQ:FOLD	Biotechnology	8.37%
Sk Biopharmaceuticals Co Ltd KO:326030	Biotechnology	0.14%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%

Annual Asset Resilience Ratio for Inovio Pharmaceuticals Inc (2000–2024)

The table below shows the annual Asset Resilience Ratio data for Inovio Pharmaceuticals Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	25.00%	$28.30 Million	$113.20 Million	-51.62pp
2023-12-31	76.62%	$130.98 Million	$170.95 Million	+17.32pp
2022-12-31	59.30%	$206.67 Million	$348.53 Million	-7.28pp
2021-12-31	66.57%	$330.17 Million	$495.94 Million	+36.76pp
2020-12-31	29.81%	$160.91 Million	$539.77 Million	-16.97pp
2019-12-31	46.78%	$67.34 Million	$143.95 Million	+2.89pp
2018-12-31	43.88%	$57.54 Million	$131.11 Million	-11.47pp
2017-12-31	55.35%	$103.64 Million	$187.24 Million	+6.06pp
2016-12-31	49.30%	$85.63 Million	$173.71 Million	+0.03pp
2015-12-31	49.27%	$105.36 Million	$213.84 Million	+8.99pp
2014-12-31	40.27%	$53.08 Million	$131.79 Million	+18.86pp
2013-12-31	21.41%	$18.91 Million	$88.29 Million	+3.62pp
2012-12-31	17.80%	$8.03 Million	$45.14 Million	-3.25pp
2011-12-31	21.05%	$12.86 Million	$61.11 Million	+17.76pp
2010-12-31	3.29%	$1.85 Million	$56.07 Million	-13.50pp
2009-12-31	16.80%	$13.54 Million	$80.63 Million	-25.94pp
2007-12-31	42.74%	$17.00 Million	$39.78 Million	+1.85pp
2006-12-31	40.89%	$14.70 Million	$35.95 Million	-1.42pp
2001-12-31	42.31%	$2.81 Million	$6.63 Million	+17.87pp
2000-12-31	24.43%	$2.81 Million	$11.49 Million	--

pp = percentage points

About Inovio Pharmaceuticals Inc

NASDAQ:INO USA Biotechnology

Market Cap

$72.83 Million

Market Cap Rank

#20424 Global

#4585 in USA

Share Price

$1.06

Change (1 day)

-3.64%

52-Week Range

$1.05 - $2.87

All Time High

$380.28